# Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial

> **NCT04395105** · PHASE3 · TERMINATED · sponsor: **Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno** · enrollment: 100 (actual)

## Conditions studied

- Respiratory Distress Syndrome, Adult
- Covid-19

## Interventions

- **DRUG:** High-Dose Dexamethasone

## Key facts

- **NCT ID:** NCT04395105
- **Lead sponsor:** Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-05-21
- **Primary completion:** 2021-04-05
- **Final completion:** 2021-05-21
- **Target enrollment:** 100 (ACTUAL)
- **Why stopped:** Low rate of recruitment
- **Last updated:** 2021-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04395105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04395105, "Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04395105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*